Bharat Biotech promoter Krishna Ella is new president of Indian Vaccine Manufacturers Association

Also Read: Bharat Biotech begins clinical trials of TB vaccine on adults

‘Pillar of global health’

“Vaccines are the vital pillar of global health, and the IVMA mission is to ensure that every individual, regardless of where they live, has access to life-saving immunisations,” Ella said adding “Innovation, sustainability, and equity are the foundations of our collective vision, and I am pleased to serve IVMA along with its distinguished members and contribute to its vision to protect and enhance public health in India and the developing world.”

He emphasised the need to support African nations’ public health vision IVMA members and also urged to formulate policies and regulations in line with WHO and US FDA, which will help the industry to be not only globally competitive but also fortify India’s vision to boost the level playing field world-over in preventive care.

“Dr Ella’s expertise and entrepreneurial spirit are exactly what the vaccine industry needs to navigate the complex challenges of the 21st century.” Dr Harshavardhan said.

IVMA’s mission is to bring to the fore the Indian private sector human vaccine manufacturers’ concerns related to the progress and profitability of the industry and to streamline regulatory pathways and matters related to audits and inspections in consultations with the national Central Drugs Standard and Control Organisation.

(Disclaimer: The headline, subheads, and intro of this report along with the photos may have been reworked by South First. The rest of the content is from a syndicated feed, and has been edited for style.)